Adalimumab (Humira®)

Categoría Resumen estructurado de revisiones sistemáticas
RevistaHTA Database
Año 2013
RECORD STATUS: This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. CITATION: All Wales Medicines Strategy Group (AWMSG). Adalimumab (Humira®) Penarth: All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG). AWMSG Secretariat Assessment Report Advice No. 2113. 2013
Epistemonikos ID: 05a43ca19c779d61bcf626caba95345f8b9a1b9a
First added on: Feb 06, 2015